HKU Scholars Hub: Browsing DSpace

Browsing by Author Ogasawara, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 5 of 5

	Title	Author(s)	Issue Date	Views
	Glycemic control is crucial for the treatment of aldose reductase inhibitor (ARI) Proceeding/Conference:Lessons from Diabetic AR-deficient Mice	Yamagishi, SI Ogasawara, S Sugawara, A Chung, SSM Chung, SK Yagihashi, S	2007	81
	Health-Related Quality-of-Life Impact of Pembrolizumab Versus Best Supportive Care in Previously Systemically Treated Patients With Advanced Hepatocellular Carcinoma: KEYNOTE-240 Journal:Cancer	Ryoo, BY Merle, P Kulkarni, AS Cheng, AL Bouattour, M Lim, HY Breder, V Edeline, J Chao, Y Ogasawara, S Yau, T Garrido, M Chan, SL Daniele, B Norquist, JM Chen, E Siegel, AB Zhu, AX Finn, RS Kudo, M	2021	28
	Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial Journal:Liver Cancer	Kudo, M Lim, HY Cheng, AL Chao, Y Yau, TCC Ogasawara, S Kurosaki, M Morimoto, N Ohkawa, K Yamashita, T Lee, KH Chen, E Siegel, AB Ryoo, BY	2020	38
	Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial Journal:Journal of Clinical Oncology	Finn, RS Ryoo, B-Y Merle, P Kudo, M Bouattour, M Lim, HY Breder, V Edeline, J Chao, Y Ogasawara, S Yau, T Garrido, M Chan, SL Knox, J Daniele, B Ebbinghaus, SW Chen, E Siegel, AB Zhu, AX Cheng, A-L The KEYNOTE-240 investigators	2020	95
	The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice Journal:Journal of Pathology	Yagihashi, S Mizukami, H Ogasawara, S Yamagishi, SI Nukada, H Kato, N Hibi, C Chung, S Chung, S	2010	193

Showing results 1 to 5 of 5